SBSHD---The SBS Group has partnered with ecbeing to strengthen its EC business support system.

SBS Holdings <2384> announced on the 28th that it has formed a business partnership with marketing partner, a group company, and ecbeing. The purpose of this partnership is to support manufacturers' mail-order businesses, aiming to enhance the speed of launching EC site construction and strengthen operation capabilities. ecbeing provides the EC construction platform "ecbeing", has over 1,600 implementation cases, and boasts the top market share in Japan for 16 consecutive years. A robust security.

Fisco Japan01:17 ET

Kokopelli --- Year-to-date high, continuing to regard the announcement of the Overseas Business matching platform as material.

Year-to-date high. The press conference for the overseas Business matching platform "BIG ADVANCE GLOBAL" held on the 24th continues to be seen as a Buy factor. This platform is scheduled to start service in June, enabling Japanese companies and overseas companies to expand sales channels and develop new suppliers. The initial target country is Thailand, with the Small and Medium Enterprises Promotion Office, 18 financial institutions providing services within Japan, and Mizuho Financial's subsidiary, Mizuho Silver.

Fisco Japan01:03 ET

Chordia --- significantly dropped, development halted for the inhibitor of the mucosal-associated lymphoid tissue lymphoma translocation protein 1.

Significantly declined. It has been announced that the strategic licensing partner, Ono Pharmaceutical Co., Ltd. <4528>, has decided to cease the development of the Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 (MALT1) inhibitor "CTX-177" for strategic reasons and return the rights related to its development, manufacturing, and commercialization to Chordia Therapeutics. Going forward, discussions will be held with Ono Pharmaceutical regarding the termination of the licensing agreement, and options will be considered.

Fisco Japan00:59 ET

Stocks that moved and those that were traded in the front market.

* Komatsu Wall <7949> 1780 - The significant increase in the dividend plan raises the appeal of the yield. * Sumitomo Pharma <4506> 787 +100 The substantial upward revision beyond expectations has an impact. * Square Enix HD <9684> 8121 +993 3D Investment emerged as a major shareholder. * S.M.S <2175> 1360 +168 The forecast of double-digit profit growth this period and the strengthening of shareholder returns are well received. * Genky Drug Stores <9267> 3630 +42

Fisco Japan00:52 ET

Kandenko, Amano ETC (Additional) Rating

Upgraded - Bullish Code Stock Name Securities Company Previous Change After----------------------------------------------------------------- <4626> Taiyo HD Morgan S "Equal W" "Over W" <8308> Resona HD Nomura "Neutral" "Buy" Target Price Change Code Stock Name Securities Company Previous Change After-------------------------------------

Fisco Japan00:02 ET

ZETA---Kao's "My Kao Mall" introduces the review, feedback, and Q&A engine "ZETA VOICE."

On the 30th, ZETA <6031> announced that its review, feedback, and Q&A engine "ZETA VOICE" has been introduced to the official online shop "My Kao Mall" operated by Kao <4452>. With this introduction, "ZETA VOICE" is supporting the improvement of UX. The site already features the EC Commodity ETF search and site search engine "ZETA SEARCH," and a recommendation engine."

Fisco Japan23:48 ET